← Back to catalogue

Buprenorphine Plus Level 1

FDA UDI

Class I (US FDA UDI)

by Utak Laboratories, Inc.

Identity

Trade Name
BUPRENORPHINE PLUS LEVEL 1 FDA UDI
Generic Name
Opiate/opiate metabolite IVD, control FDA UDI
Device Name
BUPRENORPHINE PLUS LEVEL 1 FDA UDI
Model / Reference
BUP+ 1 U PM FDA UDI
Description
BUPRENORPHINE PLUS LEVEL 1 FDA UDI

Identifiers

Primary DI / UDI-DI
B80003716500050 FDA UDI
FDA Product Code
LAS FDA UDI
GMDN Term
Opiate/opiate metabolite IVD, control FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
862.3280 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Opiate/opiate metabolite IVD, control

Buprenorphine Plus Level 1 by Utak Laboratories, Inc. — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Opiate/opiate metabolite IVD, control.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 18ad5cd4-fd80-476f-b08d-5078e902eb1b 34 fields · synced May 30, 2026